| Year |
Citation |
Score |
| 2022 |
O'Neill WW, Anderson M, Burkhoff D, Grines CL, Kapur NK, Lansky AJ, Mannino S, McCabe JM, Alaswad K, Daggubati R, Wohns D, Meraj PM, Pinto DS, Popma JJ, Moses JW, et al. Improved Outcomes in Patients with Severely Depressed LVEF Undergoing Percutaneous Coronary Intervention with Contemporary Practices: Impella-Supported High-Risk Percutaneous Coronary Intervention in Patients with Severely Depressed LVEF. American Heart Journal. PMID 35192839 DOI: 10.1016/j.ahj.2022.02.006 |
0.341 |
|
| 2020 |
Tamez H, Secemsky EA, Valsdottir LR, Moussa ID, Song Y, Simonton CA, Gibson CM, Popma JJ, Yeh RW. Long-Term Outcomes of In-Stent Restenosis Percutaneous Coronary Intervention among Medicare Beneficiaries. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. PMID 32863243 DOI: 10.4244/Eij-D-19-01031 |
0.353 |
|
| 2019 |
Rymer JA, Mandawat A, Abbott JD, Cohen MG, Davies JE, Gilchrist IC, Jolly SS, Popma JJ, Al-Khalidi HR, Rao SV, Kong D, Krucoff M. Opportunities for enhancing the care of older patients with ST-elevation myocardial infarction presenting for primary percutaneous coronary intervention: Rationale and design of the SAFE-STEMI for Seniors trial. American Heart Journal. 218: 84-91. PMID 31715434 DOI: 10.1016/j.ahj.2019.09.014 |
0.354 |
|
| 2019 |
Russo JJ, Prasad M, Doshi D, Karmpaliotis D, Parikh MA, Ali ZA, Popma JJ, Pershad A, Ohman EM, Douglas PS, O'Neill WW, Leon MB, Moses JW, Kirtane AJ. Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. PMID 31693292 DOI: 10.1002/ccd.28557 |
0.348 |
|
| 2019 |
Søndergaard L, Popma JJ, Reardon MJ, Van Mieghem NM, Deeb GM, Kodali S, George I, Williams MR, Yakubov SJ, Kappetein AP, Serruys PW, Grube E, Schiltgen MB, Chang Y, Engstrøm T, et al. Comparison of a Complete Percutaneous versus Surgical Approach to Aortic Valve Replacement and Revascularization in Patients at Intermediate Surgical Risk: Results from the Randomized SURTAVI Trial. Circulation. PMID 31476897 DOI: 10.1161/CIRCULATIONAHA.118.039564 |
0.344 |
|
| 2019 |
Kandzari DE, Karmpaliotis D, Kini AS, Moses JW, Tummala PE, Grantham JA, Orr C, Lombardi W, Nicholson WJ, Lembo NJ, Popma JJ, Wang J, Zhao W, McGreevy R. Late-term safety and effectiveness of everolimus-eluting stents in chronic total coronary occlusion revascularization: Final 4-year results from the evaluation of the XIENCE coronary stent, Performance, and Technique in Chronic Total Occlusions (EXPERT CTO) multicenter trial. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. PMID 31444897 DOI: 10.1002/ccd.28436 |
0.316 |
|
| 2019 |
Reardon MJ, Heijmen RH, Van Mieghem NM, Williams MR, Yakubov SJ, Watson D, Kleiman NS, Conte J, Chawla A, Hockmuth D, Petrossian G, Robinson N, Kappetein AP, Li S, Popma JJ. Comparison of Outcomes After Transcatheter vs Surgical Aortic Valve Replacement Among Patients at Intermediate Operative Risk With a History of Coronary Artery Bypass Graft Surgery: A Post Hoc Analysis of the SURTAVI Randomized Clinical Trial. Jama Cardiology. PMID 31215985 DOI: 10.1001/jamacardio.2019.1856 |
0.339 |
|
| 2019 |
Sharma SK, Bolduan RW, Patel MR, Martinsen BJ, Azemi T, Giugliano G, Resar JR, Mehran R, Cohen DJ, Popma JJ, Waksman R. Impact of calcification on percutaneous coronary intervention: MACE-Trial 1-year results. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. PMID 30681262 DOI: 10.1002/ccd.28099 |
0.346 |
|
| 2018 |
Shavelle DM, Banerjee S, Maini B, Schreiber TL, Kapasi N, O'Neill WW, Popma J, Matthews RV. Comparison of Outcomes of Percutaneous Coronary Intervention on Native Coronary Arteries Versus on Saphenous Venous Aorta Coronary Conduits in Patients With Low Left Ventricular Ejection Fraction and Impella Device Implantation Achieved or Attempted (from the PROTECT II Randomized Trial and the cVAD Registry). The American Journal of Cardiology. PMID 30057231 DOI: 10.1016/j.amjcard.2018.06.013 |
0.337 |
|
| 2018 |
Okada K, Honda Y, Kitahara H, Otagiri K, Tanaka S, Hollak MB, Yock PG, Popma JJ, Kusano H, Cheong WF, Sudhir K, Fitzgerald PJ, Kimura T. Bioresorbable Scaffold for Treatment of Coronary Artery Lesions: Intravascular Ultrasound Results From the ABSORB Japan Trial. Jacc. Cardiovascular Interventions. 11: 648-661. PMID 29622143 DOI: 10.1016/j.jcin.2017.11.034 |
0.301 |
|
| 2017 |
Kereiakes DJ, Ellis SG, Metzger C, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW, et al. 3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial. Journal of the American College of Cardiology. PMID 29100702 DOI: 10.1016/j.jacc.2017.10.010 |
0.332 |
|
| 2017 |
Kitahara H, Okada K, Kimura T, Yock PG, Lansky AJ, Popma JJ, Yeung AC, Fitzgerald PJ, Honda Y. Impact of Stent Size Selection on Acute and Long-Term Outcomes After Drug-Eluting Stent Implantation in De Novo Coronary Lesions. Circulation. Cardiovascular Interventions. 10. PMID 28951394 DOI: 10.1161/CIRCINTERVENTIONS.116.004795 |
0.307 |
|
| 2017 |
Cutlip DE, Garratt KN, Novack V, Barakat M, Meraj P, Maillard L, Erglis A, Jauhar R, Popma JJ, Stoler R, Silber S. 9-Month Clinical and Angiographic Outcomes of the COBRA Polyzene-F NanoCoated Coronary Stent System. Jacc. Cardiovascular Interventions. 10: 160-167. PMID 28104210 DOI: 10.1016/j.jcin.2016.10.037 |
0.326 |
|
| 2016 |
Shavelle DM, Kirtane AJ, Schreiber TL, Kapasi NK, O'Neill WW, Moses JW, Popma J, Matthews RV. Impact of Surgical Consultation on Outcomes in Hemodynamically Supported High-Risk Percutaneous Coronary Intervention: Insights From PROTECT II Randomized Study. The Journal of Invasive Cardiology. 28: 187-92. PMID 26887029 |
0.36 |
|
| 2015 |
Cohen MG, Matthews R, Maini B, Dixon S, Vetrovec G, Wohns D, Palacios I, Popma J, Ohman EM, Schreiber T, O'Neill WW. Percutaneous left ventricular assist device for high-risk percutaneous coronary interventions: Real-world versus clinical trial experience. American Heart Journal. 170: 872-9. PMID 26542494 DOI: 10.1016/j.ahj.2015.08.009 |
0.364 |
|
| 2015 |
Conte JV, Gleason TG, Resar JR, Adams DH, Deeb GM, Popma JJ, Hughes GC, Zorn GL, Reardon MJ. Transcatheter or Surgical Aortic Valve Replacement in Patients With Prior Coronary Artery Bypass Grafting. The Annals of Thoracic Surgery. PMID 26433523 DOI: 10.1016/j.athoracsur.2015.06.067 |
0.347 |
|
| 2015 |
Kereiakes DJ, Ellis SG, Popma JJ, Fitzgerald PJ, Samady H, Jones-McMeans J, Zhang Z, Cheong WF, Su X, Ben-Yehuda O, Stone GW. Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: Design of and rationale for the ABSORB III randomized trial. American Heart Journal. 170: 641-651.e3. PMID 26386787 DOI: 10.1016/j.ahj.2015.07.013 |
0.317 |
|
| 2015 |
Daubert MA, Massaro J, Liao L, Pershad A, Mulukutla S, Magnus Ohman E, Popma J, O'Neill WW, Douglas PS. High-risk percutaneous coronary intervention is associated with reverse left ventricular remodeling and improved outcomes in patients with coronary artery disease and reduced ejection fraction American Heart Journal. 170: 550-558. PMID 26385039 DOI: 10.1016/J.Ahj.2015.06.013 |
0.357 |
|
| 2015 |
Kandzari DE, Kini AS, Karmpaliotis D, Moses JW, Tummala PE, Grantham JA, Orr C, Lombardi W, Nicholson WJ, Lembo NJ, Popma JJ, Wang J, Larracas C, Rutledge DR. Safety and Effectiveness of Everolimus-Eluting Stents in Chronic Total Coronary Occlusion Revascularization: Results From the EXPERT CTO Multicenter Trial (Evaluation of the XIENCE Coronary Stent, Performance, and Technique in Chronic Total Occlusions). Jacc. Cardiovascular Interventions. 8: 761-9. PMID 25912400 DOI: 10.1016/j.jcin.2014.12.238 |
0.332 |
|
| 2015 |
Kovacic JC, Kini A, Banerjee S, Dangas G, Massaro J, Mehran R, Popma J, O'Neill WW, Sharma SK. Patients with 3-vessel coronary artery disease and impaired ventricular function undergoing PCI with Impella 2.5 hemodynamic support have improved 90-day outcomes compared to intra-aortic balloon pump: a sub-study of the PROTECT II trial. Journal of Interventional Cardiology. 28: 32-40. PMID 25689546 DOI: 10.1111/Joic.12166 |
0.368 |
|
| 2014 |
Edwards FH, Shahian DM, Grau-Sepulveda MV, Grover FL, Mayer JE, O'Brien SM, DeLong E, Peterson ED, McKay C, Shaw RE, Garratt KN, Dangas GD, Messenger J, Klein LW, Popma JJ, et al. Composite outcomes in coronary bypass surgery versus percutaneous intervention. The Annals of Thoracic Surgery. 97: 1983-8; discussion 1. PMID 24775805 DOI: 10.1016/J.Athoracsur.2014.01.087 |
0.326 |
|
| 2014 |
Dangas GD, Kini AS, Sharma SK, Henriques JP, Claessen BE, Dixon SR, Massaro JM, Palacios I, Popma JJ, Ohman M, Stone GW, O'Neill WW. Impact of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump on prognostically important clinical outcomes in patients undergoing high-risk percutaneous coronary intervention (from the PROTECT II randomized trial). The American Journal of Cardiology. 113: 222-8. PMID 24527505 DOI: 10.1016/j.amjcard.2013.09.008 |
0.347 |
|
| 2012 |
O'Neill WW, Kleiman NS, Moses J, Henriques JP, Dixon S, Massaro J, Palacios I, Maini B, Mulukutla S, Dzavík V, Popma J, Douglas PS, Ohman M. A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study. Circulation. 126: 1717-27. PMID 22935569 DOI: 10.1161/Circulationaha.112.098194 |
0.401 |
|
| 2012 |
Weintraub WS, Grau-Sepulveda MV, Weiss JM, O'Brien SM, Peterson ED, Kolm P, Zhang Z, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, et al. Comparative effectiveness of revascularization strategies. The New England Journal of Medicine. 366: 1467-76. PMID 22452338 DOI: 10.1056/NEJMoa1110717 |
0.342 |
|
| 2012 |
Weintraub WS, Grau-Sepulveda MV, Weiss JM, Delong ER, Peterson ED, O'Brien SM, Kolm P, Klein LW, Shaw RE, McKay C, Ritzenthaler LL, Popma JJ, Messenger JC, Shahian DM, Grover FL, et al. Prediction of long-term mortality after percutaneous coronary intervention in older adults: results from the National Cardiovascular Data Registry. Circulation. 125: 1501-10. PMID 22361329 DOI: 10.1161/CIRCULATIONAHA.111.066969 |
0.323 |
|
| 2012 |
Gray WA, Yeung AC, Cutlip DE, Popma JJ, Fitzgerald PJ, Williams DO, Heuer H, O'Shaughnessy CD, Overlie PA, Mann JT, Cannon LA, Hermiller JB, Henry TD, Whitbourn R, Stuckey TD, et al. A randomized, controlled, multi-center trial comparing the safety and efficacy of zotarolimus-eluting and paclitaxel-eluting stents in de novo lesions in coronary arteries: final results of the ZoMaxx II trial. International Journal of Cardiology. 157: 96-101. PMID 21658783 DOI: 10.1016/j.ijcard.2011.05.061 |
0.344 |
|
| 2012 |
Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Bonan R, Popma JJ, Cutlip DE, Fitzgerald P, Prpic R, Kuntz RE. First-in-human study of the Endeavor ABT-578-eluting phosphorylcholine-encapsulated stent system in de novo native coronary artery lesions: Endeavor I Trial. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. 1: 157-64. PMID 19758897 |
0.327 |
|
| 2011 |
Kandzari DE, Mauri L, Popma JJ, Turco MA, Gurbel PA, Fitzgerald PJ, Leon MB. Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Jacc. Cardiovascular Interventions. 4: 543-50. PMID 21596327 DOI: 10.1016/j.jcin.2010.12.014 |
0.368 |
|
| 2011 |
Otake H, Honda Y, Courtney BK, Shimohama T, Ako J, Waseda K, Macours N, Rogers C, Popma JJ, Abizaid A, Ormiston JA, Spaulding C, Cohen SA, Fitzgerald PJ. Intravascular ultrasound results from the NEVO ResElution-I trial: a randomized, blinded comparison of sirolimus-eluting NEVO stents with paclitaxel-eluting TAXUS Liberté stents in de novo native coronary artery lesions. Circulation. Cardiovascular Interventions. 4: 146-54. PMID 21386089 DOI: 10.1161/CIRCINTERVENTIONS.110.957175 |
0.313 |
|
| 2011 |
Cannon LA, Kereiakes DJ, Mann T, Popma JJ, Mooney MR, Mishkel GJ, Lee TC, Wilson BH, Stuckey TD, Orlow S, McGarry T, Ring ME, Kellett MA, Underwood P, Dawkins KD. A prospective evaluation of the safety and efficacy of TAXUS Element paclitaxel-eluting coronary stent implantation for the treatment of de novo coronary artery lesions in small vessels: the PERSEUS Small Vessel trial. Eurointervention : Journal of Europcr in Collaboration With the Working Group On Interventional Cardiology of the European Society of Cardiology. 6: 920-7, 1-2. PMID 21330238 DOI: 10.4244/EIJV6I8A161 |
0.336 |
|
| 2011 |
Dangas GD, George JC, Weintraub W, Popma JJ. Timing of staged percutaneous coronary intervention in multivessel coronary artery disease. Jacc. Cardiovascular Interventions. 3: 1096-9. PMID 20965476 DOI: 10.1016/j.jcin.2010.09.005 |
0.322 |
|
| 2010 |
Ormiston JA, Abizaid A, Spertus J, Fajadet J, Mauri L, Schofer J, Verheye S, Dens J, Thuesen L, Dubois C, Hoffmann R, Wijns W, Fitzgerald PJ, Popma JJ, Macours N, et al. Six-month results of the NEVO Res-Elution I (NEVO RES-I) trial: a randomized, multicenter comparison of the NEVO sirolimus-eluting coronary stent with the TAXUS Liberté paclitaxel-eluting stent in de novo native coronary artery lesions. Circulation. Cardiovascular Interventions. 3: 556-64. PMID 21062998 DOI: 10.1161/CIRCINTERVENTIONS.110.946426 |
0.342 |
|
| 2010 |
Kereiakes DJ, Cannon LA, Feldman RL, Popma JJ, Magorien R, Whitbourn R, Dauber IM, Rabinowitz AC, Ball MW, Bertolet B, Kabour A, Foster MC, Wang JC, Underwood P, Dawkins KD. Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System) trial. Journal of the American College of Cardiology. 56: 264-71. PMID 20493653 DOI: 10.1016/j.jacc.2010.04.011 |
0.328 |
|
| 2010 |
Naidu SS, Turco MA, Mauri L, Coolong A, Popma JJ, Kereiakes DJ. Contemporary incidence and predictors of major adverse cardiac events after saphenous vein graft intervention with embolic protection (an AMEthyst trial substudy). The American Journal of Cardiology. 105: 1060-4. PMID 20381653 DOI: 10.1016/j.amjcard.2009.12.004 |
0.338 |
|
| 2010 |
Leon MB, Mauri L, Popma JJ, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, McLaurin BT, Solomon SL, Douglas JS, Ball MW, Caputo RP, Jain A, Tolleson TR, Reen BM, et al. A Randomized Comparison of the Endeavor Zotarolimus-Eluting Stent Versus the TAXUS Paclitaxel-Eluting Stent in De Novo Native Coronary Lesions. 12-Month Outcomes From the ENDEAVOR IV Trial Journal of the American College of Cardiology. 55: 543-554. PMID 20152559 DOI: 10.1016/j.jacc.2009.08.067 |
0.38 |
|
| 2010 |
Kirtane AJ, Patel R, O'Shaughnessy C, Overlie P, McLaurin B, Solomon S, Mauri L, Fitzgerald P, Popma JJ, Kandzari DE, Leon MB. Clinical and angiographic outcomes in diabetics from the ENDEAVOR IV trial: randomized comparison of zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. Jacc. Cardiovascular Interventions. 2: 967-76. PMID 19850257 DOI: 10.1016/j.jcin.2009.08.008 |
0.344 |
|
| 2009 |
Doi H, Maehara A, Mintz GS, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Weissman NJ, Turco MA, Ormiston JA, Stone GW. Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. Jacc. Cardiovascular Interventions. 2: 1269-75. PMID 20129555 DOI: 10.1016/j.jcin.2009.10.005 |
0.309 |
|
| 2009 |
Leon MB, Kandzari DE, Eisenstein EL, Anstrom KJ, Mauri L, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, Kirtane AJ, McLaurin BT, Solomon SL, Douglas JS, Popma JJ. Late safety, efficacy, and cost-effectiveness of a zotarolimus-eluting stent compared with a paclitaxel-eluting stent in patients with de novo coronary lesions: 2-year follow-up from the ENDEAVOR IV trial (Randomized, Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Taxus Paclitaxel-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions). Jacc. Cardiovascular Interventions. 2: 1208-18. PMID 20129547 DOI: 10.1016/J.Jcin.2009.10.008 |
0.356 |
|
| 2009 |
Kandzari DE, Colombo A, Park SJ, Tommaso CL, Ellis SG, Guzman LA, Teirstein PS, Tamburino C, Ormiston J, Stone GW, Dangas GD, Popma JJ, Bass TA. Revascularization for unprotected left main disease: evolution of the evidence basis to redefine treatment standards. Journal of the American College of Cardiology. 54: 1576-88. PMID 19833256 DOI: 10.1016/j.jacc.2009.07.021 |
0.348 |
|
| 2009 |
Chambers CE, Dehmer GJ, Cox DA, Harrington RA, Babb JD, Popma JJ, Turco MA, Weiner BH, Tommaso CL. Defining the length of stay following percutaneous coronary intervention: an expert consensus document from the Society for Cardiovascular Angiography and Interventions. Endorsed by the American College of Cardiology Foundation. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 73: 847-58. PMID 19425053 DOI: 10.1002/ccd.22100 |
0.317 |
|
| 2009 |
Weisz G, Leon MB, Holmes DR, Kereiakes DJ, Popma JJ, Teirstein PS, Cohen SA, Wang H, Cutlip DE, Moses JW. Five-year follow-up after sirolimus-eluting stent implantation results of the SIRIUS (Sirolimus-Eluting Stent in De-Novo Native Coronary Lesions) Trial. Journal of the American College of Cardiology. 53: 1488-97. PMID 19389558 DOI: 10.1016/j.jacc.2009.01.050 |
0.323 |
|
| 2009 |
Liu J, Maehara A, Mintz GS, Weissman NJ, Yu A, Wang H, Mandinov L, Popma JJ, Ellis SG, Grube E, Dawkins KD, Stone GW. An integrated TAXUS IV, V, and VI intravascular ultrasound analysis of the predictors of edge restenosis after bare metal or paclitaxel-eluting stents. The American Journal of Cardiology. 103: 501-6. PMID 19195510 DOI: 10.1016/j.amjcard.2008.10.010 |
0.302 |
|
| 2008 |
Chevalier B, Di Mario C, Neumann FJ, Ribichini F, Urban P, Popma JJ, Fitzgerald PJ, Cutlip DE, Williams DO, Ormiston J, Grube E, Whitbourn R, Schwartz LB. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. Jacc. Cardiovascular Interventions. 1: 524-32. PMID 19463354 DOI: 10.1016/j.jcin.2008.08.010 |
0.377 |
|
| 2008 |
Kereiakes DJ, Turco MA, Breall J, Farhat NZ, Feldman RL, McLaurin B, Popma JJ, Mauri L, Zimetbaum P, Massaro J, Cutlip DE. A novel filter-based distal embolic protection device for percutaneous intervention of saphenous vein graft lesions: results of the AMEthyst randomized controlled trial. Jacc. Cardiovascular Interventions. 1: 248-57. PMID 19463308 DOI: 10.1016/J.Jcin.2008.03.009 |
0.31 |
|
| 2008 |
Ellis SG, O'Shaughnessy CD, Martin SL, Kent K, McGarry T, Turco MA, Kereiakes DJ, Popma JJ, Friedman M, Koglin J, Stone GW. Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: The TAXUS V ISR trial European Heart Journal. 29: 1625-1634. PMID 18556716 DOI: 10.1093/eurheartj/ehn231 |
0.338 |
|
| 2008 |
Coolong A, Baim DS, Kuntz RE, O'Malley AJ, Marulkar S, Cutlip DE, Popma JJ, Mauri L. Saphenous vein graft stenting and major adverse cardiac events: a predictive model derived from a pooled analysis of 3958 patients. Circulation. 117: 790-7. PMID 18212287 DOI: 10.1161/CIRCULATIONAHA.106.651232 |
0.342 |
|
| 2007 |
Meredith IT, Ormiston J, Whitbourn R, Kay IP, Muller D, Popma JJ, Cutlip DE, Fitzgerald PJ. Four-year clinical follow-up after implantation of the endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study. The American Journal of Cardiology. 100: 56M-61M. PMID 17950833 DOI: 10.1016/j.amjcard.2007.08.023 |
0.311 |
|
| 2007 |
Gershlick A, Kandzari DE, Leon MB, Wijns W, Meredith IT, Fajadet J, Popma JJ, Fitzgerald PJ, Kuntz RE. Zotarolimus-eluting stents in patients with native coronary artery disease: clinical and angiographic outcomes in 1,317 patients. The American Journal of Cardiology. 100: 45M-55M. PMID 17950832 DOI: 10.1016/j.amjcard.2007.08.021 |
0.304 |
|
| 2007 |
Kereiakes DJ, Teirstein PS, Sarembock IJ, Holmes DR, Krucoff MW, O'Neill WW, Waksman R, Williams DO, Popma JJ, Buchbinder M, Mehran R, Meredith IT, Moses JW, Stone GW. The truth and consequences of the COURAGE trial. Journal of the American College of Cardiology. 50: 1598-603. PMID 17936161 DOI: 10.1016/J.Jacc.2007.07.063 |
0.34 |
|
| 2007 |
Moses JW, Weisz G, Mishkel G, Caputo R, O'shaughnessey C, Wong SC, Fischell TA, Mooney M, Williams DO, Popma JJ, Fitzgerald P, Smith S, Kuntz RE, Collins M, Cohen SA, et al. The SIRIUS-DIRECT trial: a multi-center study of direct stenting using the sirolimus-eluting stent in patients with de novo native coronary artery lesions. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 70: 505-12. PMID 17896408 DOI: 10.1002/ccd.21162 |
0.355 |
|
| 2007 |
Holmes DR, Kereiakes DJ, Laskey WK, Colombo A, Ellis SG, Henry TD, Popma JJ, Serruys PW, Kimura T, Williams DO, Windecker S, Krucoff MW. Thrombosis and drug-eluting stents: an objective appraisal. Journal of the American College of Cardiology. 50: 109-18. PMID 17616294 DOI: 10.1016/j.jacc.2007.04.032 |
0.331 |
|
| 2006 |
Kandzari DE, Leon MB, Popma JJ, Fitzgerald PJ, O'Shaughnessy C, Ball MW, Turco M, Applegate RJ, Gurbel PA, Midei MG, Badre SS, Mauri L, Thompson KP, LeNarz LA, Kuntz RE. Comparison of Zotarolimus-Eluting and Sirolimus-Eluting Stents in Patients With Native Coronary Artery Disease. A Randomized Controlled Trial Journal of the American College of Cardiology. 48: 2440-2447. PMID 17174180 DOI: 10.1016/j.jacc.2006.08.035 |
0.314 |
|
| 2006 |
Moses JW, Nikolsky E, Mehran R, Cambier PA, Bachinsky WB, Leya F, Kuntz RE, Popma JJ, Schleckser P, Wang H, Cohen SA, Leon MB. Safety and efficacy of the 2.25-mm sirolimus-eluting Bx Velocity stent in the treatment of patients with de novo native coronary artery lesions: the SIRIUS 2.25 trial. The American Journal of Cardiology. 98: 1455-60. PMID 17126649 DOI: 10.1016/j.amjcard.2006.06.047 |
0.32 |
|
| 2006 |
Fajadet J, Wijns W, Laarman GJ, Kuck KH, Ormiston J, Münzel T, Popma JJ, Fitzgerald PJ, Bonan R, Kuntz RE. Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial. Circulation. 114: 798-806. PMID 16908773 DOI: 10.1161/CIRCULATIONAHA.105.591206 |
0.34 |
|
| 2006 |
Jonas M, Fang JC, Wang JC, Giri S, Elian D, Har-Zahav Y, Ly H, Seifert PA, Popma JJ, Rogers C. In-stent restenosis and remote coronary lesion progression are coupled in cardiac transplant vasculopathy but not in native coronary artery disease. Journal of the American College of Cardiology. 48: 453-61. PMID 16875968 DOI: 10.1016/j.jacc.2006.01.081 |
0.33 |
|
| 2006 |
Ali A, Cox D, Dib N, Brodie B, Berman D, Gupta N, Browne K, Iwaoka R, Azrin M, Stapleton D, Setum C, Popma J. Rheolytic Thrombectomy With Percutaneous Coronary Intervention for Infarct Size Reduction in Acute Myocardial Infarction. 30-Day Results From a Multicenter Randomized Study Journal of the American College of Cardiology. 48: 244-252. PMID 16843170 DOI: 10.1016/j.jacc.2006.03.044 |
0.313 |
|
| 2006 |
Schampaert E, Moses JW, Schofer J, Schlüter M, Gershlick AH, Cohen EA, Palisaitis DA, Breithardt G, Donohoe DJ, Wang H, Popma JJ, Kuntz RE, Leon MB. Sirolimus-eluting stents at two years: a pooled analysis of SIRIUS, E-SIRIUS, and C-SIRIUS with emphasis on late revascularizations and stent thromboses. The American Journal of Cardiology. 98: 36-41. PMID 16784917 DOI: 10.1016/j.amjcard.2006.01.049 |
0.329 |
|
| 2006 |
Stone GW, Ellis SG, O'Shaughnessy CD, Martin SL, Satler L, McGarry T, Turco MA, Kereiakes DJ, Kelley L, Popma JJ, Russell ME. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. Jama. 295: 1253-63. PMID 16531618 DOI: 10.1001/jama.295.11.1253 |
0.325 |
|
| 2006 |
Kwok OH, Chow WH, Law TC, Chiu A, Ng W, Lam WF, Hong MK, Popma JJ. First human experience with angiopeptin-eluting stent: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 66: 541-6. PMID 16208695 DOI: 10.1002/ccd.20558 |
0.342 |
|
| 2005 |
Moussa I, Ellis SG, Jones M, Kereiakes DJ, McMartin D, Rutherford B, Mehran R, Collins M, Leon MB, Popma JJ, Russell ME, Stone GW. Impact of coronary culprit lesion calcium in patients undergoing paclitaxel-eluting stent implantation (a TAXUS-IV sub study). The American Journal of Cardiology. 96: 1242-7. PMID 16253590 DOI: 10.1016/j.amjcard.2005.06.064 |
0.322 |
|
| 2005 |
Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, O'Shaughnessy CD, DeMaio S, Hall P, Popma JJ, Koglin J, Russell ME. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: a randomized controlled trial. Jama. 294: 1215-23. PMID 16160130 DOI: 10.1001/jama.294.10.1215 |
0.306 |
|
| 2005 |
Ellis SG, Popma JJ, Lasala JM, Koglin JJ, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Stone GW. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation: Analysis from the TAXUS-IV trial Journal of the American College of Cardiology. 45: 1193-1200. PMID 15837248 DOI: 10.1016/j.jacc.2004.11.063 |
0.307 |
|
| 2005 |
Fischell TA, Maheshwari A, Mirza RA, Haller S, Carter AJ, Popma JJ. Impact of frame selection on quantitative coronary angiographic analysis after coronary stenting. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 64: 460-7. PMID 15789391 DOI: 10.1002/ccd.20344 |
0.314 |
|
| 2005 |
Ly HQ, Kirtane AJ, Buros J, Giugliano RP, Popma JJ, Antman EM, Harrington RA, Ohman EM, Gibson CM. Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction. The American Journal of Cardiology. 95: 383-6. PMID 15670549 DOI: 10.1016/J.AMJCARD.2004.09.038 |
0.324 |
|
| 2005 |
Sketch MH, Ball M, Rutherford B, Popma JJ, Russell C, Kereiakes DJ. Evaluation of the Medtronic (Driver) cobalt-chromium alloy coronary stent system. The American Journal of Cardiology. 95: 8-12. PMID 15619386 DOI: 10.1016/j.amjcard.2004.08.055 |
0.35 |
|
| 2004 |
Popma JJ, Leon MB, Moses JW, Holmes DR, Cox N, Fitzpatrick M, Douglas J, Lambert C, Mooney M, Yakubov S, Kuntz RE. Quantitative assessment of angiographic restenosis after sirolimus-eluting stent implantation in native coronary arteries. Circulation. 110: 3773-80. PMID 15596568 DOI: 10.1161/01.CIR.0000150331.14687.4B |
0.363 |
|
| 2004 |
Cox N, Resnic FS, Popma JJ, Simon DI, Eisenhauer AC, Rogers C. Comparison of the risk of vascular complications associated with femoral and radial access coronary catheterization procedures in obese versus nonobese patients. The American Journal of Cardiology. 94: 1174-7. PMID 15518615 DOI: 10.1016/j.amjcard.2004.07.088 |
0.49 |
|
| 2004 |
Sawhney N, Moses JW, Leon MB, Kuntz RE, Popma JJ, Bachinsky W, Bass T, DeMaio S, Fry E, Holmes DR, Teirstein PS. Treatment of left anterior descending coronary artery disease with sirolimus-eluting stents. Circulation. 110: 374-9. PMID 15249503 DOI: 10.1161/01.CIR.0000136580.34604.B8 |
0.351 |
|
| 2004 |
Stankovic G, Colombo A, Bersin R, Popma J, Sharma S, Cannon LA, Gordon P, Nukta D, Braden G, Collins M. Comparison of directional coronary atherectomy and stenting versus stenting alone for the treatment of de novo and restenotic coronary artery narrowing. The American Journal of Cardiology. 93: 953-8. PMID 15081434 DOI: 10.1016/j.amjcard.2003.12.047 |
0.385 |
|
| 2004 |
Schampaert E, Cohen EA, Schlüter M, Reeves F, Traboulsi M, Title LM, Kuntz RE, Popma JJ. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). Journal of the American College of Cardiology. 43: 1110-5. PMID 15028375 DOI: 10.1016/j.jacc.2004.01.024 |
0.331 |
|
| 2004 |
Holmes DR, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, Snead D, Kuntz RE. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 109: 634-40. PMID 14769686 DOI: 10.1161/01.CIR.0000112572.57794.22 |
0.321 |
|
| 2004 |
Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, Turco M, Caputo R, Bergin P, Greenberg J, Popma JJ, Russell ME. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. The New England Journal of Medicine. 350: 221-31. PMID 14724301 DOI: 10.1056/NEJMoa032441 |
0.355 |
|
| 2003 |
Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, Caputo RP, Kereiakes DJ, Williams DO, Teirstein PS, Jaeger JL, Kuntz RE. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. The New England Journal of Medicine. 349: 1315-23. PMID 14523139 DOI: 10.1056/NEJMoa035071 |
0.383 |
|
| 2003 |
Kereiakes DJ, Szyniszewski AM, Wahr D, Herrmann HC, Simon DI, Rogers C, Kramer P, Shear W, Yeung AC, Shunk KA, Chou TM, Popma J, Fitzgerald P, Carroll TE, Forer D, et al. Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results. Circulation. 108: 1310-5. PMID 12939212 DOI: 10.1161/01.CIR.0000087602.91755.19 |
0.337 |
|
| 2003 |
Stone PH, Coskun AU, Kinlay S, Clark ME, Sonka M, Wahle A, Ilegbusi OJ, Yeghiazarians Y, Popma JJ, Orav J, Kuntz RE, Feldman CL. Effect of endothelial shear stress on the progression of coronary artery disease, vascular remodeling, and in-stent restenosis in humans: in vivo 6-month follow-up study. Circulation. 108: 438-44. PMID 12860915 DOI: 10.1161/01.Cir.0000080882.35274.Ad |
0.315 |
|
| 2003 |
Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, Feres F, Mattos LA, Falotico R, Jaeger J, Popma JJ, Serruys PW. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation. 107: 381-3. PMID 12551858 DOI: 10.1161/01.CIR.0000051720.59095.6D |
0.323 |
|
| 2003 |
Sousa JE, Costa MA, Abizaid A, Sousa AG, Feres F, Mattos LA, Centemero M, Maldonado G, Abizaid AS, Pinto I, Falotico R, Jaeger J, Popma JJ, Serruys PW. Sirolimus-eluting stent for the treatment of in-stent restenosis: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation. 107: 24-7. PMID 12515737 DOI: 10.1161/01.CIR.0000047063.22006.41 |
0.325 |
|
| 2003 |
Resnic FS, Wainstein M, Lee MK, Behrendt D, Wainstein RV, Ohno-Machado L, Kirshenbaum JM, Rogers CD, Popma JJ, Piana R. No-reflow is an independent predictor of death and myocardial infarction after percutaneous coronary intervention. American Heart Journal. 145: 42-6. PMID 12514653 DOI: 10.1067/mhj.2003.36 |
0.497 |
|
| 2003 |
Silva JA, White CJ, Ramee SR, Collins TJ, Jenkins JS, Ho K, Baim DS, Carrozza JP, Rinfret S, Setum CM, Popma JJ, Kuntz RE. Treatment of coronary stent thrombosis with rheolytic thrombectomy: results from a multicenter experience. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 58: 11-7. PMID 12508190 DOI: 10.1002/ccd.10385 |
0.37 |
|
| 2002 |
Dixon SR, Whitbourn RJ, Dae MW, Grube E, Sherman W, Schaer GL, Jenkins JS, Baim DS, Gibbons RJ, Kuntz RE, Popma JJ, Nguyen TT, O'Neill WW. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. Journal of the American College of Cardiology. 40: 1928-34. PMID 12475451 DOI: 10.1016/S0735-1097(02)02567-6 |
0.33 |
|
| 2002 |
Stone GW, Rogers C, Ramee S, White C, Kuntz RE, Popma JJ, George J, Almany S, Bailey SR. Distal filter protection during saphenous vein graft stenting: technical and clinical correlates of efficacy. Journal of the American College of Cardiology. 40: 1882-1888. PMID 12446075 DOI: 10.1016/S0735-1097(02)02129-0 |
0.315 |
|
| 2002 |
Mauri L, Bonan R, Weiner BH, Legrand V, Bassand JP, Popma JJ, Niemyski P, Prpic R, Ho KK, Chauhan MS, Cutlip DE, Bertrand OF, Kuntz RE. Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial. The American Journal of Cardiology. 90: 1079-83. PMID 12423707 |
0.335 |
|
| 2002 |
Popma JJ, Cox N, Hauptmann KE, Reifart N, Virmani R, Emira K, Murphy S, Gibson CM, Grube E. Initial clinical experience with distal protection using the FilterWire in patients undergoing coronary artery and saphenous vein graft percutaneous intervention. Catheterization and Cardiovascular Interventions : Official Journal of the Society For Cardiac Angiography & Interventions. 57: 125-34. PMID 12357506 DOI: 10.1002/ccd.10313 |
0.398 |
|
| 2002 |
Holmes DR, Savage M, LaBlanche JM, Grip L, Serruys PW, Fitzgerald P, Fischman D, Goldberg S, Brinker JA, Zeiher AM, Shapiro LM, Willerson J, Davis BR, Ferguson JJ, Popma J, et al. Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial. Circulation. 106: 1243-50. PMID 12208800 DOI: 10.1161/01.CIR.0000028335.31300.DA |
0.324 |
|
| 2002 |
Baim DS, Wahr D, George B, Leon MB, Greenberg J, Cutlip DE, Kaya U, Popma JJ, Ho KK, Kuntz RE. Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation. 105: 1285-90. PMID 11901037 |
0.361 |
|
| Show low-probability matches. |